Issue Information

Issue Information
Publié: (2024)

Issue Information
Publié: (2024)

Issue Information
Publié: (2026)

Issue Information
Publié: (2025)

Issue Information
Publié: (2026)

Issue Information
Publié: (2025)

Issue Information
Publié: (2025)

Issue Information
Publié: (2025)

Issue Information
Publié: (2025)

Issue Information
Publié: (2026)

Issue Information
Publié: (2026)

Issue Information
Publié: (2025)

Issue Information
Publié: (2025)

Issue Information
Publié: (2025)

Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
par: Alexandre Duong, et autres
Publié: (2024)

Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
par: Mohammed Al Musawa, et autres
Publié: (2024)

Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
par: Hua‐Ping Fan, et autres
Publié: (2024)

“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
par: Carlos Augusto Espinoza Cobeñas
Publié: (2024)

Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
par: Lisa T. Hong, et autres
Publié: (2024)

Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
par: Shibing Tao, et autres
Publié: (2024)

External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring
par: Mathieu Blouin, et autres
Publié: (2024)

The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review
par: Hansa Mreyoud, et autres
Publié: (2024)

Comment on “The power and pitfalls of underpowered studies”
par: Chia Siang Kow, et autres
Publié: (2024)

Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”
par: Yongyi Zhang, et autres
Publié: (2024)

Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency
par: Zhiheng Yu, et autres
Publié: (2024)

Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
par: David B. Cluck, et autres
Publié: (2024)

Use of proton pump inhibitors and risk of severe COVID‐19: A case–control study in United States Medicare beneficiaries
par: Andrew D. Mosholder, et autres
Publié: (2024)

Update and narrative review of avian influenza (H5N1) infection in adult patients
par: Mohammed Aldhaeefi, et autres
Publié: (2024)

Warfarin dosage in a postpartum woman while breastfeeding: A case report
par: Ellen Uppuluri, et autres
Publié: (2024)

Pain management considerations in patients living with both pain syndromes and cardiovascular diseases and disorders
par: Emily E. Leppien, et autres
Publié: (2024)

Simulated cost‐effectiveness of a novel precision‐guided dosing strategy in adult patients with Crohn's disease initiating infliximab maintenance therapy
par: Elmar R. Alizadeh, et autres
Publié: (2024)

Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: A population‐based study
par: Mennatullah Hasan, et autres
Publié: (2024)

Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta‐analysis
par: C. Michael White, et autres
Publié: (2024)

Current and emerging PCSK9‐directed therapies to reduce LDL‐C and ASCVD risk: A state‐of‐the‐art review
par: Candice L. Garwood, et autres
Publié: (2024)

Platelet glycoprotein IIb/IIIa antagonists in ischemic stroke patients without endovascular therapy: A meta‐analysis
par: Dongjun Xu, et autres
Publié: (2024)

ECLIPSES: Early initiation of sodium glucose cotransporter‐2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrome and subsequent coronary artery bypass graft surgery
par: Lena Makortoff, et autres
Publié: (2024)